Insightec

This registry follows 50 people with tremor-dominant Parkinson's disease who have undergone a focused ultrasound thalamotomy. The procedure uses sound waves to target a small area in the brain that causes tremors. The goal is to collect long-term safety data and measure how well …

This study is testing a device called ExAblate 4000 that uses focused ultrasound waves to treat non-cancerous brain tumors in children and young adults. The goal is to see if the treatment is safe and can shrink tumors without open surgery. About 20 participants will be enrolled,…

This study tests whether a second focused ultrasound treatment on the opposite side of the brain can further reduce tremors in people with essential tremor who already had one treatment. About 100 participants will be randomly assigned to get the second procedure or continue stan…

This early-stage study tests whether a focused ultrasound technique can safely open the blood-brain barrier to deliver a Parkinson's drug directly to a key brain area. Fourteen participants with mild to moderate Parkinson's will receive the treatment. The main goal is to check sa…

This study tracks people with advanced Parkinson's disease who receive a treatment called Exablate, which uses focused ultrasound to target a small area in the brain. The goal is to see how well it reduces medication-resistant motor problems like shaking and stiffness. Researcher…

This study is testing if a device called ExAblate can safely open the blood-brain barrier in people with Alzheimer's disease. The goal is to see if this helps ease symptoms. About 50 adults aged 50-85 with probable Alzheimer's will take part. The study focuses on safety and how w…

This early study tests whether low-intensity focused ultrasound (LIFU) can safely help people with opioid or other substance use disorders. Researchers will treat 29 adults who are already in outpatient addiction programs. The main goal is to see if the procedure is well-tolerate…